Generation Bio Co. ( GBIO) - Key Metrics
Stock symbol GBIO is outdated, potentially delisted? Maybe it is available on other exchange?
GBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.11 | -$3.12 | -$2.51 | -$2.58 |
| 2025Q1 | $1.30 | -$2.21 | -$4.23 | -$4.27 |
| 2024Q4 | $0.63 | -$3.20 | -$2.37 | -$2.42 |
| 2024Q3 | $1.13 | -$2.29 | -$2.93 | -$2.94 |
| 2024Q2 | $0.61 | -$3.07 | -$3.24 | -$3.24 |
GBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | -0.26 |
| 2025Q1 | ? | -0.46 |
| 2024Q4 | ? | -0.83 |
| 2024Q3 | ? | -2.69 |
| 2024Q2 | ? | -2.09 |
GBIO
Price: $5.34
52 week price:
Earnings Per Share: -9.37 USD
P/E Ratio: -0.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16029
Market Capitalization: 38.0 million